Status:
TERMINATED
Intravenous Acetaminophen Use With Bariatric Surgery on Morbidly Obese Patients
Lead Sponsor:
Trinity Health Of New England
Conditions:
Obesity
Pain
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Bariatric patients usually require the use of either intravenous or oral opioid medications. The use of opioids, however, is often associated with side-effects such as nausea, sedation pruritus, urina...
Eligibility Criteria
Inclusion
- Morbidly Obese and body mass index (BMI) of 35
- Between ages 20-17
- Candidates for Laparoscopic Bariatric Surgery
Exclusion
- know hypersensitivity to acetaminophen or opioids
- impairment in liver function
- renal dysfunction
- mental retardation
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT01527942
Start Date
March 1 2012
End Date
July 1 2013
Last Update
December 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Francis Hospital
Hartford, Connecticut, United States, 06105